Copyright
©The Author(s) 2016.
World J Gastroenterol. Mar 14, 2016; 22(10): 2922-2930
Published online Mar 14, 2016. doi: 10.3748/wjg.v22.i10.2922
Published online Mar 14, 2016. doi: 10.3748/wjg.v22.i10.2922
Parameter | Score | ||
1 | 2 | 3 | |
Encephalopathy | None | Grade I-II | Grade III-IV |
Ascites | Absent | Mild | Moderate to Severe |
Albumin | > 3.5 g/dL | 2.8-3.5 g/dL | < 2.8 g/dL |
Prothrombin time prolongation over control (in seconds) or INR | < 4 | 4-6 | > 6 |
< 1.7 | 1.7-2.3 | > 2.3 | |
Total Bilirubin | < 2 mg/dL | 2-3 mg/dL | > 3 mg/dL |
Status | Characteristics |
11 | Patients with fulminant liver failure or those who their newly transplanted liver does not function |
2A | Patients with chronic liver disease, in critical care unit and with life expectancy of < 7 d. They have a CTP score ≥ 10 and meet other medical criteria. |
2B | Patients with chronic liver disease becoming more urgently in need of a liver transplantation but do not meet the criteria of status 2A. They have a CTP score ≥ 10, or a CTP score of ≥ 7 and at least one of the other medical criteria. |
3 | Patients with chronic liver disease under medical care but not admitted in the hospital and do not meet the criteria for status 2B. |
Status 1A: adult or pediatric patient with fulminant hepatic failure |
Status 1B: severely ill pediatric patient ( ≤ 18 yr) with MELD or PELD ≥ 25, in ICU |
Calculated MELD/PELD score |
Exceptional MELD or PELD score |
Status 7: inactive status, temporarily unsuitable for transplant |
- Citation: Schilsky ML, Moini M. Advances in liver transplantation allocation systems. World J Gastroenterol 2016; 22(10): 2922-2930
- URL: https://www.wjgnet.com/1007-9327/full/v22/i10/2922.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i10.2922